8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.
People assigned to a diet, food or program and measured.
2024 / Double-blind randomized controlled trial
In a 24-week double-blind randomized trial, 80 patients with NASFL were assigned to 500 mg/day curcumin or placebo. Compared with placebo, curcumin significantly reduced controlled attenuation parameters (-17.5 dB/m; P < 0.001), body weight (-2.6 kg; P < 0.001), BMI (-1.0 kg/m2; P = 0.032), free fatty acids, triglycerides, fasting blood glucose, HbA1c, and insulin. Curcumin also decreased the Firmicutes to Bacteroidetes ratio, increased Bacteroides abundance, elevated serum deoxycholic acid and glucagon-like peptide-1, and increased TGR5 expression.
He Y, Chen X, Li Y, et al. Am J Clin Nutr, 2024. PMID 38795741
2024 / Randomized, double-blind split-mouth clinical trial
In a randomized, double-blind split-mouth trial, 20 patients aged 18-25 years took kale extract (500 mg anthocyanin equivalent) or ibuprofen (400 mg) capsules for 7 days following surgical removal of impacted teeth. VAS pain scores and salivary α-amylase decreased 7 days after extractions in both groups, with kale extract reported as more effective than ibuprofen. MMP-9 and TGF-β2 levels were reduced on days 4 and 7 following both extractions in the kale group, compared to reductions on days 4 and 7 only after the first extraction in the ibuprofen group.
Chatupos V, Neelawatanasook S, Sangutai T, et al. Nutrients, 2024. PMID 39599607
2023 / Randomized controlled trial
A community-based randomized controlled trial evaluated the effects of water immersion at 20-30°C (20 min/day for 4 weeks) versus a control group among 76 acute gout patients in Indonesia. Compared to baseline and control, water immersion led to significant pain alleviation at 2 weeks (β = -2.06) and 4 weeks (β = -2.42), as well as improved quality of life at 2 weeks (β = 5.34) and 4 weeks (β = 9.93). Urate levels decreased at 2 weeks (β = -0.34, 95% CI: -0.52 to -0.16) but showed no significant change in NLRP1 inflammasome concentrations across 4 weeks.
Kurniasari MD, Karwur FF, Rayanti RE, et al. Biol Res Nurs, 2023. PMID 36207143
2023 / Single-center, prospective, randomized, single-blind clinical trial
Adults with an increased 10-year risk of ASCVD were randomized to rosuvastatin 5 mg daily, placebo, fish oil, cinnamon, garlic, turmeric, plant sterols, or red yeast rice for 28 days. A total of 190 participants completed the trial. Rosuvastatin achieved a greater percent LDL-C reduction than all supplements and placebo (P < 0.001), with a -35.2% difference compared with placebo (95% CI: -41.3% to -29.1%; P < 0.001). None of the dietary supplements demonstrated a significant decrease in LDL-C compared with placebo, and adverse event rates were similar across groups.
Laffin LJ, Bruemmer D, Garcia M, et al. J Am Coll Cardiol, 2023. PMID 36351465
2023 / Randomized, double-blind, controlled clinical trial
Sixty patients with Alzheimer's disease were randomized to receive either 500 mg/day spirulina twice daily or placebo for 12 weeks. Compared with placebo, spirulina significantly improved MMSE score (+0.30 ± 0.99 vs. -0.38 ± 1.06, p = 0.01). Spirulina also reduced hs-CRP (-0.17 ± 0.29 vs. +0.05 ± 0.27 mg/L, p = 0.006), fasting glucose (-4.56 ± 7.93 vs. +0.80 ± 2.95 mg/dL, p = 0.002), insulin (-0.37 ± 0.62 vs. +0.12 ± 0.40 μIU/mL, p = 0.001), and insulin resistance (-0.08 ± 0.13 vs. 0.03 ± 0.08, p = 0.001), while increasing insulin sensitivity (+0.003 ± 0.005 vs. -0.001 ± 0.003, p = 0.003).
Tamtaji OR, Heidari-Soureshjani R, Asemi Z, et al. Phytother Res, 2023. PMID 36861852
2022 / 8-week single-blinded randomized controlled trial
An 8-week single-blind randomized controlled trial evaluated the effects of 10 g/day dried barberry versus placebo in 84 participants with cardiovascular risk factors. Body weight, BMI, physical activity, and dietary intake did not differ between groups. After adjusting for baseline values, the barberry group showed significant decreases compared to placebo in TG (p < 0.001), TC (p = 0.011), LDL-C (p = 0.015), sd-LDL-C (p = 0.019), non-HDL-C (p = 0.004), TC/HDL-C (p = 0.039), and CRP (p = 0.020).
Emamat H, Zahedmehr A, Asadian S, et al. BMC Complement Med Ther, 2022. PMID 35255880
2022 / Randomized, double-blind clinical trial
Hemodialysis patients aged 20-75 were randomized to receive 12 weeks of turmeric alone (3 g/day) or turmeric with piperine (3 g turmeric + 2 mg piperine/day). The turmeric/piperine group showed significantly greater reductions in MDA [-0.08(-0.14/0.01) nmol/mL vs -0.003(-0.10/0.26) nmol/mL, p=0.003] and ferritin [-193.80 ± 157.29 mg/mL vs 51.99 ± 293.25 mg/mL, p=0.018] compared to turmeric alone. Additionally, GPx activity decreased in the turmeric group (p=0.029), while no changes were observed for CAT, GR, or hs-CRP.
Freitas E Silva-Santana NC, Rodrigues HCN, Pereira Martins TF, et al. Free Radic Biol Med, 2022. PMID 36370961
2021 / Randomized, double-blind, crossover trial
Sixteen overweight older adults consumed a high-fat high-energy meal with 250 mL of either anthocyanin-rich Queen Garnet Plum juice or control apricot juice in a randomized crossover trial. Compared to control, the anthocyanin arm had higher 2-hour postprandial flow-mediated dilatation (+1.14%, P = 0.019) and higher microvascular post-occlusive reactive hyperaemia (+0.10 perfusion units per mmHg, P = 0.049). C-reactive protein was lower at 4 hours postprandially in the anthocyanin arm (1.80 mg/L) compared with control (2.30 mg/L, P = 0.026). No significant postprandial differences were found for blood pressure, lipids, oxidative metabolites, or other inflammatory markers.
do Rosario VA, Chang C, Spencer J, et al. Clin Nutr, 2021. PMID 33071012
2020 / 3-month self-selection pilot trial
A 3-month self-selection pilot study evaluated a watermelon-focused Inflammation Management Intervention (n = 15) versus basic health education controls (n = 8). There were no group-by-time interactions for any studied outcomes. Post hoc analyses grouped participants by change in energy-adjusted Dietary Inflammatory Index (E-DII) score, noting that some intervention participants became more proinflammatory and several controls became more anti-inflammatory. Those with more anti-inflammatory dietary changes (below median E-DII change) showed differences in body fat percent (-1.27% vs +0.90%, P = .01), BMI (-0.66 vs +0.38 kg/m2, P = .06), and body weight (-0.99 vs +0.54 kg, P = .08).
Wirth MD, Shivappa N, Khan S, et al. Nutr Metab Insights, 2020. PMID 31975781
2020 / Controlled feeding studies
Volunteers consumed either a 60% kcal fat meal (n=98) or a 36% kcal fat meal (n=62, placebo group). At least 87.5% of plasma LPS measurements in 32 tested participants were below the assay sensitivity (0.002 EU/mL). Although polymyxin B suppressed IL-1β (P = 0.035) and IL-6 (P = 0.0487) production in 3 h postprandial blood after 24 h incubation in the 60% fat study, the LPS present did not increase cytokine concentrations above fasting levels. In vitro lipoprotein lipase treatment significantly increased FFA and cytokine concentrations (P < 0.05) in both studies.
Mo Z, Huang S, Burnett DJ, et al. J Nutr, 2020. PMID 32040591
2020 / Intervention trial with matched controls
Adult-onset mitochondrial myopathy patients and matched controls received increasing doses of the vitamin B3 form niacin (up to 750-1,000 mg/day) for 10 or 4 months, respectively. Blood NAD+ increased in all subjects up to 8-fold, and muscle NAD+ in patients reached control levels. Muscle strength and mitochondrial biogenesis increased in all subjects, patients' muscle metabolomes shifted toward controls, and liver fat decreased by as much as 50%, though some patients showed an anemia tendency.
Pirinen E, Auranen M, Khan NA, et al. Cell Metab, 2020. PMID 32386566
2020 / Randomized double-blind placebo-controlled trial
Fifty patients with migraine were randomized to receive either cinnamon powder (three capsules/day, each containing 600 mg) or placebo (three capsules/day of corn starch) for 2 months. Compared with the control group, serum concentrations of IL-6 and NO were significantly reduced in the cinnamon group (p < .05), while CGRP levels remained unchanged in both groups. In addition, the frequency, severity, and duration of migraine attacks significantly decreased in the cinnamon group compared to controls.
Zareie A, Sahebkar A, Khorvash F, et al. Phytother Res, 2020. PMID 32638445
2019 / Parallel randomized clinical trial
A parallel randomized clinical trial evaluated the effect of consuming 240 ml of soy milk daily as part of a 500-calorie deficit diet compared to the deficit diet alone for 8 weeks in 70 patients with NAFLD. The soy milk group showed significantly greater reductions in serum alanine aminotransferase (-12.06 ± 17.61 IU/L vs. -5 ± 8.58 IU/L, p = 0.04) and hs-CRP (-1.32 ± 1.60 mg/L vs. -0.36 ± 1.54 mg/L, p = 0.01). However, changes in fatty liver grade, other liver enzymes (AST, ALP, GGT), lipid profiles, and anthropometric indices did not differ significantly between groups.
Eslami O, Shidfar F, Maleki Z, et al. J Am Coll Nutr, 2019. PMID 30028245
2019 / Randomized controlled trial
In an 8-week randomized trial of 40 adolescent boys with active nonalcoholic fatty liver disease, restricting free sugars to under 3% of daily calories reduced hepatic steatosis from 25% to 17%, compared with 21% to 20% in the usual diet group (adjusted mean difference -6.23%; 95% CI, -9.45% to -3.02%; P < .001). Alanine aminotransferase levels decreased more with the low-sugar diet (adjusted ratio of geometric means 0.65; 95% CI, 0.53 to 0.81; P < .001). Seven secondary outcomes were null.
Schwimmer JB, Ugalde-Nicalo P, Welsh JA, et al. JAMA, 2019. PMID 30667502
2019 / Randomized, double-blind trial
In a randomized, double-blind trial, adults aged 45 to 79 with symptomatic knee osteoarthritis consumed either 40 g of freeze-dried blueberry powder (n = 33) or placebo powder (n = 30) daily for four months. The blueberry group experienced significant decreases in WOMAC total score, pain, stiffness, and difficulty performing daily activities (p < 0.05), whereas improvements in total score and daily activities were not seen with placebo. In the blueberry group, normal walking pace single support percentage increased for both limbs (p ≤ 0.007) and double support percentage decreased (p ≤ 0.003). No significant changes were observed in plasma concentrations of TNF-α, IL-1β, IL-6, IL-10, IL-13, MMP-3, MMP-13, and MCP-1 in either group, though trends were observed for IL-13 and MCP-1 in the blueberry group.
Du C, Smith A, Avalos M, et al. Nutrients, 2019. PMID 30699971
2019 / Randomized crossover trial
In a randomized crossover study of obese adults with type 2 diabetes, acute raspberry intake lowered postprandial serum glucose at two and four hours and decreased IL-6 and hsTNF-alpha at four hours (p < 0.05). Following four weeks of daily supplementation, IL-6 and hsTNF-alpha remained significantly reduced compared to control periods (p < 0.05). The intervention did not alter fasting blood sugar, blood lipids, C-reactive protein, or vascular elasticity.
Schell J, Betts NM, Lyons TJ, et al. Ann Nutr Metab, 2019. PMID 30763939
2019 / Randomized controlled clinical trial
Fifty-five obese women without baseline selenium deficiency were randomly assigned to consume 1 unit/d of Brazil nuts (~1261 μg/Se) or no intervention for 2 months. In the Brazil nut group, all selenium biomarkers and the gene expression of proinflammatory parameters (interleukin-6, tumor necrosis factor-α, and Toll-like receptors 2 and 4) increased significantly (P < 0.05). No changes occurred in the control group. While plasma inflammatory biomarker levels did not change, the authors concluded that the increased gene expression may indicate a proinflammatory stimulus induced by high-selenium Brazil nut consumption in obesity.
Duarte GBS, Reis BZ, Rogero MM, et al. Nutrition, 2019. PMID 31026738
2019 / Two-phase double-blind randomized clinical trial
A two-phase, double-blind randomized clinical trial evaluated the effects of consuming a flavonoid-rich cocoa beverage daily for up to 12 weeks. In the initial study (60 subjects aged 55-70), the flavonoid-rich group showed improvements in glycemia, triglyceridemia, HDL, LDL, the triglyceridemia/HDL index, oxidative markers, the Up and Go test, skeletal muscle index, and quality of life compared to placebo or non-flavonoid cocoa. In the follow-up study (74 subjects aged 65-90), flavonoid treatment significantly improved metabolic, oxidative stress, and inflammatory endpoints, along with positive effects on physical performance, frailty indicators, and quality of life compared with the non-flavonoid beverage.
Munguia L, Rubio-Gayosso I, Ramirez-Sanchez I, et al. J Gerontol A Biol Sci Med Sci, 2019. PMID 31056655
2019 / Randomized, parallel, controlled trial
Sixty-six patients with NAFLD were randomly assigned to a 500-calorie deficit diet either with or without 240 ml/day of soy milk for 8 weeks. Compared to the control group, the soy milk group showed significantly greater reductions in serum insulin (-3.44 ± 5.02 vs. -1.09 ± 3.77 μIU/ml, P = 0.04), HOMA-IR (-0.45 ± 0.64 vs -0.14 ± 0.47, P = 0.03), systolic BP (-3.81 ± 4.15 vs -1.48 ± 2.93 mmHg, P = 0.01), and diastolic BP (-2.39 ± 2.80 vs. -0.94 ± 2.76 mmHg, P = 0.04), plus a significant increase in QUICKI (0.02 ± 0.032 vs. 0.008 ± 0.018, P = 0.04). Changes in fasting blood sugar, HOMA-β%, fibrinogen, and malondialdehyde did not differ significantly between groups.
Maleki Z, Jazayeri S, Eslami O, et al. Complement Ther Med, 2019. PMID 31126574
2019 / Randomized crossover trial
Seventeen healthy young subjects consumed a high-fat meal (HFM) along with water, fruit juice, or champagne in a randomized crossover design. Across the whole group, the HFM caused significant hypertriglyceridemia (from 0.77 ± 0.07 to 1.41 ± 0.18 mmol/L, p < 0.001) without overall impairment of FMD. However, in 10 subjects where HFM decreased FMD (from 10.73 ± 0.95 to 8.1 3± 0.86 and 8.07 ± 1.16%; p < 0.05 and p < 0.01 at 2 and 3 hours, respectively), FMD did not decrease when drinking juice or champagne. The authors concluded that fruit juice or champagne might reduce such alterations, though further studies are needed to determine the mechanisms.
Rouyer O, Auger C, Charles AL, et al. J Clin Med, 2019. PMID 31208093
2019 / Single-arm pilot intervention trial
Seventeen women aged 20 to 45 with Hashimoto's thyroiditis participated in a 10-week online health coaching program implementing the Autoimmune Protocol elimination diet. Among the 16 women who completed questionnaires, statistically significant improvements were observed across all eight SF-36 subscales, and the MSQ symptom burden decreased from an average of 92 (SD 25) to 29 (SD 20). High-sensitivity C-reactive protein (n = 14) decreased significantly by 29% (p = 0.0219), from 1.63 mg/L (SD 1.72) to 1.15 mg/L (SD 1.31). No statistically significant changes were observed in thyroid function tests or thyroid antibodies.
Abbott RD, Sadowski A, Alt AG Cureus, 2019. PMID 31275780
2019 / Pilot study
A pilot study evaluated the postprandial effects of high-fat/high-glycemic load meals enriched with blueberries in 5 obese/overweight patients with metabolic syndrome. Significant decreases in urinary methylamines, acetoacetate, acetone, and succinate were observed at 2 and 4 hours post-ingestion, alongside accumulation of gut-derived phenolic acids. In mononuclear blood cells, mRNA expression of interleukin-6 significantly decreased and transforming growth factor-β significantly increased following blueberry supplementation.
Sobolev AP, Ciampa A, Ingallina C, et al. Metabolites, 2019. PMID 31295937
2019 / Randomized clinical trial
In this randomized clinical trial, 43 patients with type 2 diabetes and chronic periodontitis were randomly allocated to receive resveratrol supplements or placebo for 4 weeks alongside non-surgical periodontal therapy. In the intervention group, the mean serum level of IL6 decreased significantly post-intervention from 2.19 ± 1.09 to 1.58 ± 1.06 (P = 0.039). However, no significant differences were observed between the intervention and control groups post-intervention for IL6, TNFα, TAC, or CAL.
Javid AZ, Hormoznejad R, Yousefimanesh HA, et al. Diabetes Metab Syndr, 2019. PMID 31405706
2019 / Placebo-controlled, randomized, double-blind, crossover trial
In a randomized, double-blind, placebo-controlled crossover study, 12 aged men received 1 g per day of oral nicotinamide riboside (NR) or placebo for 21 days. Targeted metabolomics demonstrated that NR increased the muscle NAD+ metabolome, as shown by higher nicotinic acid adenine dinucleotide and nicotinamide clearance products. Muscle RNA sequencing showed downregulation of energy metabolism and mitochondrial pathways, though mitochondrial bioenergetics were not altered. Additionally, NR supplementation reduced circulating inflammatory cytokine levels.
Elhassan YS, Kluckova K, Fletcher RS, et al. Cell Rep, 2019. PMID 31412242